The clinic group is soon to be acquired by the Geneva-based shipping giant. The restructuring is expected to be completed by the end of 2026.

This new center is designed to accelerate the development of neuromodulation technologies for psychiatric and neurological disorders.

On World AIDS Day 2025, the International AIDS Society (IAS) and Geneva University Hospitals (HUG) announced that Geneva has been…

Valais-based Pacrim Group has taken a major strategic step in the Swiss life-science landscape by acquiring a controlling majority of Medropharm AG, a pioneer in pharmaceutical-grade cannabis. Announced on 21 October 2025, the transaction positions Pacrim — together with its subsidiary Alponics SA — as Switzerland’s only fully integrated medicinal cannabis enterprise, spanning the entire value chain from plant genetics to patient-ready products.

Japonese company Takeda has reached an important milestone in Western Switzerland with the inauguration of a new aseptic filling facility…

Artiria Medical, an EPFL spinoff and Swiss innovator in neurovascular technologies, announces that its SmartGUIDE™ 014 deflectable guidewire, a next-generation…

Cell and gene therapies are promising, but remain extremely expensive. The pharmaceutical company Bracco Imaging, a leader in medical imaging,…

Vivent Biosignals, the Vaud-based pioneer of “wearables for plants”, has announced new investment from Agri Investment Fund (AIF), Horticoop, Pymwymic…

The Swiss Health Valley continues to demonstrate its strength as a European powerhouse in life sciences, medtech, and biotechnology. In…

Since its founding in 2015, the Biofactory Competence Center (BCC) in Fribourg is a unique biopharmaceutical training and research institution…

The Biopôle-based company (Vaud) developed the DEXTER® Robotic Surgery System, a soft tissue surgical robot that uniquely simplifies operations to…

Apply before 8 February 2026 for the BioInnovation Day, the Swiss Health Valley flagship event for early-stage life sciences projects.